HER2 Targeting in Esophagogastric Cancer: Redefining the Landscape and Breaking Barriers
Journal of the National Comprehensive Cancer Network · 2023-04 · 21 (4) · 423-429
DOI: 10.6004/jnccn.2023.7010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023-04. Verfasst von Samuel L Cytryn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, New York, New York. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Stomach Neoplasms, Immunoconjugates. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
HER2 is overexpressed in approximately 20% of esophagogastric cancer (EGC) cases. The addition of the anti-HER2 antibody, trastuzumab, to chemotherapy in 2010 was the first targeted treatment to demonstrate an improvement in survival. The aggressive nature and heterogeneous biology of EGC have posed a particular challenge and resulted in numerous negative trials without a change in standard of care for more than a decade. However, with the incorporation of dual HER2 and PD-1 blockade as well as the advent of a new, potent antibody–drug conjugate, trastuzumab deruxtecan, there have been 2 new FDA approvals for this patient population within the past 2 years. Consequently, the management and landscape of HER2-positive EGC is rapidly changing and increasingly optimistic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Memorial Sloan Kettering Cancer Center, New York, New York.
Zitieren
APA
Cytryn, S. L., & Janjigian, Y. Y. (2023). HER2 Targeting in Esophagogastric Cancer: Redefining the Landscape and Breaking Barriers. Journal of the National Comprehensive Cancer Network, 21(4), 423-429. https://doi.org/10.6004/jnccn.2023.7010
Vancouver
Cytryn SL, Janjigian YY. HER2 Targeting in Esophagogastric Cancer: Redefining the Landscape and Breaking Barriers. Journal of the National Comprehensive Cancer Network. 2023;21(4):423-429. doi:10.6004/jnccn.2023.7010
BibTeX
@article{Cytryn2023,
author = {Cytryn, Samuel L and Janjigian, Yelena Y},
title = {HER2 Targeting in Esophagogastric Cancer: Redefining the Landscape and Breaking Barriers},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2023},
volume = {21},
number = {4},
pages = {423--429},
doi = {10.6004/jnccn.2023.7010}
}
EUVIMED